Posts by: Jose Marques Lopes, PhD

News

Treatment with synthetic RNA molecules targeting the C5 complement system protein in the liver may be effective in people with myasthenia gravis (MG), according to a new study in ... Read more

May 9, 2019May 9, 2019

#AANAM – Under-the-Skin Immunoglobulin Treatment Maintains Stable Disease Activity, Study Reports

News

Treatment with subcutaneous immunoglobulin (SCIg) — a new formulation given as an under-the-skin injection — enabled people with myasthenia gravis (MG) to maintain stable disease activity while transitioning from ... Read more

March 28, 2019March 28, 2019

MG Should Be Suspected in Patients with Voice Alterations, Case Report Says

News

A recent report described a rare case of a woman presenting with a sudden decrease in voice volume who was ultimately diagnosed and successfully treated for myasthenia gravis (MG). ... Read more

March 26, 2019March 26, 2019

Soliris May Be Best Immunotherapy for MG Patients, Study Suggests

News

Soliris (eculizumab) may be the most effective and well-tolerated immunotherapy for patients with myasthenia gravis (MG), according to an analysis of multiple studies. The research, “Immunosuppressive and monoclonal antibody ... Read more

February 28, 2019February 28, 2019

Most MG Patients, Especially Men and Patients With Late-onset Disease, Respond to Plasma Exchange

News

A vast majority of patients with myasthenia gravis (MG) responded to treatment with plasma exchange and half experienced symptom relief, according to a study. The findings also showed that ... Read more

February 19, 2019February 19, 2019

Soliris Shows Sustained Efficacy and Safety for gMG in Extension Study

News

Treatment with Soliris (eculizumab) provided adults with generalized myasthenia gravis (gMG) clinically meaningful improvements through three years in daily living, muscle strength, functional ability and quality of life, according ... Read more

February 12, 2019February 12, 2019

Treatment Shows Favorable Outcomes for Patients with Juvenile Myasthenia Gravis, Study Reports

News

Treatment of juvenile myasthenia gravis (JMG) lessens the severity of symptoms in most patients, leading to stable remission without significant amounts of medication, according to a study of Polish ... Read more

January 24, 2019January 24, 2019

Flu Vaccine Safe and Effective for AChR Antibody-positive MG Patients, Study Reports

News

Patients with myasthenia gravis (MG), who are positive for the acetylcholine receptor (AChR) antibody, respond effectively to influenza vaccination, even if taking immunosuppressants. Also, influenza vaccination is safe, and ... Read more

January 10, 2019January 10, 2019

Phase 2b Trial Finds Firdapse Effective, Safe in Adults with MuSK-MG

News

Treatment of adult MuSK-antibody positive myasthenia gravis (MuSK-MG) patients with the investigational therapy Firdapse (amifampridine phosphate) improved muscle strength, eased fatigue, and was safe, according to full results of a Phase 2b ... Read more

January 8, 2019January 8, 2019

Researchers Develop New Test for Rapid, Less-costly Test to Detect Anti-AChR Antibodies in Myasthenia Gravis Patients

News

A new test offers a rapid, sensitive and inexpensive way to detect anti-acetylcholine receptor (AChR) antibodies in patients with myasthenia gravis (MG). The study with that finding, “A Simple, ... Read more

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

RNA Molecules Targeting C5 Complement Protein May Be Effective in MG

#AANAM – Under-the-Skin Immunoglobulin Treatment Maintains Stable Disease Activity, Study Reports

MG Should Be Suspected in Patients with Voice Alterations, Case Report Says

Soliris May Be Best Immunotherapy for MG Patients, Study Suggests

Most MG Patients, Especially Men and Patients With Late-onset Disease, Respond to Plasma Exchange

Soliris Shows Sustained Efficacy and Safety for gMG in Extension Study

Treatment Shows Favorable Outcomes for Patients with Juvenile Myasthenia Gravis, Study Reports

Flu Vaccine Safe and Effective for AChR Antibody-positive MG Patients, Study Reports

Phase 2b Trial Finds Firdapse Effective, Safe in Adults with MuSK-MG

Researchers Develop New Test for Rapid, Less-costly Test to Detect Anti-AChR Antibodies in Myasthenia Gravis Patients

Pin It on Pinterest